Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: A new treatable disorder

Neurology

Volumn 75, Issue 7, 2010, Pages 641-645

  Lion Francois L ^a   Mignot, C ^c,d,e   Vicart, S ^d,e   Manel, V ^b   Sternberg, D ^d,e   Landrieu, P ^f   Lesca, G ^g   Broussolle, E ^h,i,j   Billette De Villemeur, T ^c,d   Napuri, S ^k   Des Portes, V ^a   Fontaine, B ^d,e  

^a Service de Neurologie Pédiatrique   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f BICÊTRE HOSPITAL   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h UNIVERSITÉ DE LYON   (France)

ⁱ HÔPITAL NEUROLOGIQUE   (France)

^j CNRS   (France)

^k SERVICE DE RHUMATOLOGIE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; LEVODOPA; MEXILETINE; SODIUM CHANNEL NAV1.4;

APNEA; ARTICLE; CASE REPORT; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ELECTROMYOGRAPHY; HUMAN; HUMAN TISSUE; LARYNX SPASM; MALE; MISSENSE MUTATION; MUSCLE BIOPSY; MUSCLE HYPERTROPHY; MYOTONIA; NEWBORN; NEWBORN DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SEVERE NEWBORN EPISODIC LARYNGOSPASM;

EID: 77955856284     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181ed9e96     Document Type: Article

References (10)

1. Praveen V, Patole SK, Whitehall JS. Hyperekplexia in ne-onates. Postgrad Med J 2001;77:570-572.
2. Yis U, Kurul SH, Oztura I, Ozden O, Akinci G, Dirik E. Temporary diazepam responsive apneic attacks and congenital myasthenic syndrome. J Child Neurol 2009;24: 895-898.
3. Mignot C, Doummar D, Maire I, De Villemeur TB. Type 2 Gaucher disease: 15 new cases and review of the literature. Brain Dev 2006;28:39-48.
4. Meola G, Hanna MG, Fontaine B. Diagnosis and new treatment in muscle channelopathies. J Neurol Neurosurg Psychiatry 2009;80:360-365.
5. Colding-Jorgensen E, Duno M, Vissing J. Autosomal dominant monosymptomatic myotonia permanens. Neurology 2006;67:153-155.
6. Ferriby D, Stojkovic T, Sternberg D, Hurtevent JF, Hurtevent JP, Vermersch P. A new case of autosomal dominant myotonia associated with the V1589M missense mutation in the muscle sodium channel gene and its phe-notypic classification. Neuromuscul Disord 2006;16:321-324.
7. Gay S, Dupuis D, Faivre L, et al. Severe neonatal non-dystrophic myotonia secondary to a novel mutation of the voltage-gated sodium channel (SCN4A) gene. Am J Med Genet A 2008;146:380-383.
8. Matthews E, Guet A, Mayer M, et al. Neonatal hypotonia can be a sodium channelopathy: recognition of a new phe-notype. Neurology 2008;71:1740-1742.
9. Tsujino A, Maertens C, Ohno K, et al. Myasthenic syndrome caused by mutation of the SCN4A sodium channel. Proc Natl Acad Sci USA 2003;100:7377-7382.
10. Hayward LJ, Brown RH Jr, Cannon SC. Inactivation defects caused by myotonia associated mutations in the sodium channel III-IV linker. J Gen Physiol 1996;107: 559-576.